Earnings PreviewATRA
ATRA Shorts Scramble as Stock Doubles in a Month
Atara Biotherapeutics reports Q1 2026 results today with a short-selling community caught badly offside — the stock has more than doubled in a month, and borrowed shares are being unwound in a hurry. The price action…
1 min read
